Discover how outdoor therapy aids stroke recovery, enhancing strength and mental well-being through nature's healing benefits ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

While most stroke survivors can usually recover some function through treatment and rehabilitation, they tend to hit a “major plateau” after the first six months of recovery, he said. Vivistim, when ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

For ventricular tachycardia after myocardial infarction, outcomes are better with upfront catheter ablation than drug therapy ...

Boston Scientific (NYSE:BSX) announced positive three-year primary endpoint results from a clinical trial of its Watchman FLX ...

The trial met its primary safety and efficacy endpoints, demonstrating the device's superiority to oral anticoagulants.

Over 2 decades ago, the aldosterone antagonist eplerenone proved beneficial after MI complicated by left ventricular ...

The Portable Neuromodulation Stimulator ("PoNS”) is an innovative, non-implantable, orally applied therapy ... in stroke ...

Leaders with Mercy Health Youngstown and Lifepoint Rehabilitation celebrated the grand opening of the new Mercy Health ...

That Thursday, for the first time, the European Medicines Agency (EMA) approved a drug that targets the cause — not just the ...